N-(4,5-dihydroacenaphtho[5,4-d]thiazol-8-yl)-2-(4-methylphenylsulfonamido)benzamide

ID: ALA4472741

Chembl Id: CHEMBL4472741

Cas Number: 361173-49-1

PubChem CID: 5214717

Max Phase: Preclinical

Molecular Formula: C27H21N3O3S2

Molecular Weight: 499.62

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)Nc2ccccc2C(=O)Nc2nc3c(cc4c5c(cccc53)CC4)s2)cc1

Standard InChI:  InChI=1S/C27H21N3O3S2/c1-16-9-13-19(14-10-16)35(32,33)30-22-8-3-2-6-20(22)26(31)29-27-28-25-21-7-4-5-17-11-12-18(24(17)21)15-23(25)34-27/h2-10,13-15,30H,11-12H2,1H3,(H,28,29,31)

Standard InChI Key:  CIHQUXBPVARSBW-UHFFFAOYSA-N

Associated Targets(non-human)

NS4A Hepatitis C virus serine protease, NS3/NS4A (1215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 499.62Molecular Weight (Monoisotopic): 499.1024AlogP: 5.91#Rotatable Bonds: 5
Polar Surface Area: 88.16Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.26CX Basic pKa: CX LogP: 6.44CX LogD: 6.13
Aromatic Rings: 5Heavy Atoms: 35QED Weighted: 0.31Np Likeness Score: -1.83

References

1. Ren J, Ojeda I, Patel M, Johnson ME, Lee H..  (2019)  Exploring small molecules with pan-genotypic inhibitory activities against hepatitis C virus NS3/4A serine protease.,  29  (16): [PMID:31201062] [10.1016/j.bmcl.2019.06.009]

Source